In [1], the incorrect Fig. 3 was published on page 413. The corrected Fig. 3 is shown below.
Fig. 3.
Modulation of HLA-DR and CD86 expression by anti-IgM or CpG-ODN. Purified adult and cord blood B cells were cultured with medium alone (filled plots) or stimulated for 48 h with F(ab′)2 anti-IgM (10 µg/ml), CpG-ODN 2080 (30 µg/ml) or non-CpG ODN 2078 (30 µg/ml) (open plots). Anti-IgM was added to cultures at 0 h and ODN were added at 0 h, 2 h and 23 h. Cells were dual-stained for expression of CD19 and HLA-DR or CD19 and CD86 and histograms of marker expression on CD19 positive cells are shown (a). Collated data from four separate experiments shows the mean fluorescence indices (mean ± s.d.) for HLA-DR (b) and CD86 expression (c) on CD19+ cells.
The authors apologize for this error.
REFERENCE
- 1.Tasker L, Marshall-Clarke S. Functional responses of human neonatal B lymphocytes to antigen receptor cross-linking and CpG DNA. Clin Exp Immunol. 2003;134:409–19. doi: 10.1111/j.1365-2249.2003.02318.x. [DOI] [PMC free article] [PubMed] [Google Scholar]